Gossamer Bio Inc

-0.02 (-0.27%)
Earnings Announcements

Gossamer Bio Announces Q1 2022 Results

Published: 05/10/2022 20:59 GMT
Gossamer Bio Inc (GOSS) - Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update.
Gossamer Bio - Sees Current Cash, Cash Equivalents, Marketable Securities, Access to Debt Facility to Be Sufficient to Fund Operating & Capex Into 2024.
Qtrly Net Loss per Share, Basic and Diluted $0.76.
Q1 Earnings per Share View $-0.77 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.68

More details on our Analysts Page.